Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-02

Clinical Trial Update: Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring predictors of symptom relapse after discontinuation of treatment in overactive bladder patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KYU-SUNG LEE | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED